Search
The combined group will focus on delivering innovative cancer diagnostics to address unmet needs in early cancer detection.

Biotech companies in $24m merger

South Perth-based Bard1 Life Sciences is forming a new cancer diagnostic business with a fellow listed medtech company in Victoria.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 29/05/20

1 year TSR5 year TSR
30thPYC Therapeutics249%30%
165thBARD1 Life Sciences56%6%
497thDigital Wine Ventures-17%-15%
541st4DS Memory-23%5%
671 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

22/11/19
$12k Bought
23/10/19
$0 Bought
12/07/19
$10k Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

153rd↑BARD1 Life Sciences$571k
179th↑Digital Wine Ventures$39k
180th↑4DS Memory$39k
184th↑Thred$5k
186th↓PYC Therapeutics$250
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®